Focus on Ovarian and Gynecologic Cancers
The study found that women with ovarian cancer who took the drug tended to live longer than those who did not take it.
A new study suggests that the common diabetes medication metformin may be considered for use in the prevention or treatment of ovarian cancer. Published in CANCER, a journal of the American Cancer Society, the study found that women with ovarian cancer who took the drug tended to live longer than those who did not take it.
As cancer survival rates improve, there is an increasing need for simple, user-friendly resources that help survivors document their care and plan for life after cancer. To fill the void for this type of information for survivors of gynecologic cancers, the Foundation for Gynecologic Oncology is making available to patients and doctors a set of gynecologic cancer survivorship tools beginning in September, Gynecologic Cancer Awareness Month.
by Andrew Berchuck, MD
Every year 22,000 women in the United States will be newly diagnosed with ovarian cancer. More women are living as survivors because therapy can significantly prolong life and, in some cases, cure the disease. For women facing a diagnosis of ovarian cancer, the options for treatment have grown in recent years.